clinical trials

June 25, 2015

My Four Takeaways from the 2015 ASCO Annual Meeting

English

Patient advocate Diana Chingos wanted to attend the 2015 ASCO Annual Meeting to learn about the latest cancer research. After four intense days of posters and presentations, she left Chicago with a mountain of new knowledge and four key insights.

Read More >>
June 4, 2015
Cat Snyder, ASCO staff

Expert Conversations: Bladder Cancer

English
catherine.snyder

In this podcast, experts Charles Ryan, MD, and Thomas Powles, MD, talk about bladder cancer treatment, including some of the new approaches that are being developed.

Read More >>
June 2, 2015
Amber Bauer, ASCO staff

Progress through Cancer Research: Helping People Live Longer, Better Lives

English
amber.bauer

Two out of three people now live at least five years after being diagnosed with cancer, but there is still more to be done. Researchers at the 2015 ASCO Annual Meeting showed how new treatment options can continue to improve and lengthen the lives of people with both rare and common cancers.

Read More >>
May 30, 2015
Amber Bauer, ASCO staff

A Targeted Approach to Treatment: Research from the 2015 ASCO Annual Meeting

English
amber.bauer

This year, President Obama has focused attention on treatments and tools that help doctors tailor medical care for individual patients. Research presented at the 2015 ASCO Annual Meeting shows how targeted therapies can be used to improve the care of people with a number of different types of blood cancer.

Read More >>
April 14, 2015
Cat Snyder, ASCO staff

Expert Conversations: Kidney Cancer

English
catherine.snyder

First in this podcast series, Dr. Brian Rini shares his perspective on current and new approaches to kidney cancer treatment.

Read More >>
2015 Genitourinary Cancers Symposium
February 24, 2015
Amber Bauer, ASCO staff

New Prostate Cancer Research Presented at 2015 Genitourinary Cancers Symposium

English
amber.bauer

Get highlights of four studies that address ways to improve the care of men with prostate cancer. Results include the identification of a potential risk factor, better ways to select the best treatment option, and new insight into the debate over prostate-specific antigen (PSA) screening.

Read More >>

Pages

Subscribe to RSS - clinical trials